Results 201 to 210 of about 27,203 (237)
Some of the next articles are maybe not open access.
Removal of Basiliximab by Plasmapheresis
American Journal of Kidney Diseases, 2001Basiliximab is a chimeric monoclonal antibody directed against the alpha chain of interleukin-2 (IL-2) receptors. Given its expected volume of distribution (plasma volume), therapeutic plasmapheresis may be expected to lower serum Basiliximab levels. A 20-mg dose of Basiliximab was given before plasmapheresis.
Herwig Ulf Meier-Kriesche +5 more
openaire +3 more sources
Clinics in Rheumatic Diseases, 1982
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +3 more sources
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +3 more sources
Plasmapheresis: Technique and complications
Intensive Care Medicine, 1990Plasmapheresis has been used in an increasing number of diverse conditions over the past 15 years, and patients on intensive care units are sometimes so treated. This article reviews the principles, different techniques and refinements available, including the more specific methods of antibody removal, such as immunoadsorption.
P. M. Reimann, P. D. Mason
openaire +3 more sources
Plasmapheresis for neurological disorders
Expert Review of Neurotherapeutics, 2009Apheresis is a general term that describes removal of abnormal blood constituents by extracorporeal blood purification methods. To date, therapeutic plasma exchange (PE) is the most common apheresis procedure. Here, plasma is separated from corpuscular blood constituents and replaced with a substitution fluid.
Ralf A. Linker +2 more
openaire +3 more sources
Plasmapheresis in Solar Urticaria [PDF]
Dermatology, 1991 Three patients with solar urticaria were treated with plasmapheresis. By intradermal injection of in vitro irradiated serum the existence of a circulating photoallergen was demonstrated in cases 1 and 2 but not in case 3. Plasmapheresis induced complete remission of solar urticaria in case 1 and transient improvement in case 2.
Gerd Plewig +4 more
openaire +3 more sources
DeckerMed Nephrology, Dialysis, and Transplantation, 2002
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +3 more sources
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +3 more sources
Plasmapheresis in Hyperviscosity Syndrome
Acta Medica Scandinavica, 1985ABSTRACT Three patients with Waldenström's macroglobulinaemia developed circulatory complications due to increased plasma viscosity, i.e relative viscosity value above 4. Plasmapheresis was performed either in a Haemonetics 30 S cell separator, by plasma filtration through a CPS 10 TM filter or by a double‐double pack Fenwal® system.
Erik Hippe +3 more
openaire +3 more sources
Vox Sanguinis, 1986
Abstract. Manual plasmapheresis is done worldwide on both paid donors, and to a much smaller extent on volunteer donors in order to generate source plasma to be fractionated into albumin, clotting factor concentrates, and gamma globulin. Automated technology has now been developed utilizing both centrifugal, and membrane separation devices (Haemonetics
openaire +2 more sources
Abstract. Manual plasmapheresis is done worldwide on both paid donors, and to a much smaller extent on volunteer donors in order to generate source plasma to be fractionated into albumin, clotting factor concentrates, and gamma globulin. Automated technology has now been developed utilizing both centrifugal, and membrane separation devices (Haemonetics
openaire +2 more sources
Plasmapheresis in a Patient With Scleromyxedema
Archives of Dermatology, 1987We describe a patient with progressive scleromyxedema who failed to respond to previously described treatment modalities. A trial of plasmapheresis was initiated, but after an initial promising response, his disease continued to progress. The skin involvement appeared to progress even more rapidly after the plasmapheresis was discontinued.
Donald P. Lookingbill, Alan I. Westheim
openaire +3 more sources
Plasmapheresis in the Dysproteinemias
Therapeutic Apheresis, 2002Abstract: The dysproteinemias consist of a broad range of serious disease states with the common thread of excessive production of an abnormal, or para‐protein. Various clinical syndromes may arise, either from the underlying disease process, the excess paraprotein, or both.
openaire +3 more sources